Page results
-
Testing for NHS staff, provided by the Francis Crick Institute and UCLH NHS Foundation Trust, detected COVID-19 infections that would have otherwise been missed.
-
The Integrated Children and Adolescent Service is a long-established outpatient service of the Royal London Hospital for Integrated Medicine at UCLH.
-
NHS England has published a proposed interim specification for the new services for children and young people experiencing gender dysphoria.
-
We are very excited that the Omnipod 5 has now been launched. The team have been busy over the last few months getting training and ensuring that the pump is on our procurement system.
-
UCLH Find & Treat team explain why screening is vital on World Hepatitis Day
-
This page explains what spasticity is. It contains information on botulinum toxin and its use to treat conditions such as spasticity and dystonia which can occur after a stroke or brain injury.
-
This page provides information on examinations using contrast agents in MRI. It is intended for use by patients (or their families or carers) who have been referred to our service for imaging requiring contrast agents.
-
The National Day Care Unit provides an opportunity for many people to receive different treatments, tests and procedures without having to stay overnight in the hospital. Some eligible patients who need more than one day of treatment will stay in a hotel near to the hospital.
-
Using MRI alongside PSA density allowed detection of cancers that would have been missed by the blood test alone, according to research from UCLH, UCL and King’s College London.
-
The Elizabeth Garrett Anderson maternity service at UCLH has been rated ‘Good’ following an inspection by the Care Quality Commission (CQC) in June 2023.
File results
-
FOI/2024/0312 - Cleaning brushes and theatre equipment in sterilisation decontamination unit
-
FOI/2024/0317 - Physician associate/ Anaesthesia associate shift hours 2010-2023
-
FOI/2024/0318 - Patients absconded from medium/ high-security psychiatric facilities
-
FOI/2024/0320 - Treatment for rare diseases; fabry, gaucher and pompe diseases
-
FOI/2024/0326 - Treatment of Haemophilia B and Von Willebrand disease
-
FOI/2024/0327 - Treatment of non-UK nationals
-
FOI/2024/0329 - Metastatic renal cell carcinoma patients/ classification
-
FOI/2024/0464 - Theatre sessions/ productivity
-
FOI/2024/0467 - Drug Patient Level Contract Monitoring (DrPLCM) and SACT Cancer reports
-
FOI/2024/0333 - Elective treatment wait over 65 weeks